The Australian Therapeutic Goods and Drugs Administration (TGA) has granted provisional approval for the use of the drug tocilizumab in the treatment of COVID-19. Sold under the brand name “ACTEMRA” and produced by Roche, the drug is already an approved treatment for arthritis and inflammatory conditions and is the fourth COVID-19 treatment to be given…
Australian Regulatory Body Grants Approval for New COVID-19 Treatment
UK Approves Rheumatoid Arthritis Drugs for COVID-19 Treatment
The UK on Thursday approved two drugs to be used in treating patients with COVID-19, a disease caused by the CCP (Chinese Communist Party) virus, commonly known as novel coronavirus. The two new drugs, tocilizumab and sarilumab, typically used to treat rheumatoid arthritis, are monoclonal antibodies that target a protein called interleukin-6, which is thought to be important in…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`